Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Echo Therapeutics logo — company profile

Echo Therapeutics

Founded 1989 United States United States 8 employees Post Ipo Debt Total: $44.70M Biotechnology, Health Care +2

General Information

Company Name Echo Therapeutics
Founded Year 1989
Location United States United States +3
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Post Ipo Debt
Social

Get notified when Echo Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Echo Therapeutics

Echo Therapeutics, established in 1989, focuses on developing a non-invasive, wireless, continuous glucose monitoring (CGM) system. The company's CGM system holds potential for application in the outpatient diabetes market, as well as in the fitness, weight loss, and wearable-health sector. Additionally, it presents a longer-term opportunity in hospital settings. Echo has also introduced a needle-free skin preparation device as a platform technology, enabling improved skin permeation for the extraction of analytes, including glucose, and enhanced delivery of topical pharmaceuticals. The company, headquartered in the United States, received a $1.79M Post-IPO Debt investment on February 8, 2016. Although the last investment details do not specify the investors, this funding underscores investor interest in Echo Therapeutics' innovative approach in the Biotechnology, Health Care, Health and Wellness, and Medical Devices industries.

Taxonomy: medical device, glucose monitoring, continuous glucose monitoring, wearable health technology, diabetes management, non-invasive sensing, skin preparation technology, transdermal drug delivery, hospital critical care, wireless health monitoring

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• - 08 Feb 2016
Post-IPO Equity •••••• - 22 Dec 2014
Post-IPO Equity •••••• 2
Investor
•••• •••• 		19 Dec 2013
Post-IPO Equity •••••• - 20 Jun 2013
Post-IPO Equity •••••• - 15 Feb 2011

View All 10 Funding Rounds

Echo Therapeutics Alternatives & Competitors

Echo Therapeutics vs
Nemaura Medical
Nemaura Medical

Innovative wearable diagnostic devices empowering individuals to manage and prevent diabetes through...

Post Ipo Debt
Health Care
Echo Therapeutics vs
Undermyfork
Undermyfork United States

Personal nutrition insights for better time in range

Seed
7 employees
Health Care
Echo Therapeutics vs
Pacific Diabetes Technologies Inc
Pacific Diabetes Technologies Inc United States

Simplifying diabetes management

20 employees
Health Care

FAQ About Echo Therapeutics

Echo Therapeutics is developing its non-invasive, wireless, continuous glucose monitoring (CGM) system. A significant opportunity exists for the Company’s CGM to be used in the outpatient diabetes market and in the fitness, weight loss and personal lifestyle wearable-health space. A longer-term oppo...
Echo Therapeutics was founded in 1989.
Echo Therapeutics is headquartered in United States.
Echo Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Medical Devices.
Echo Therapeutics has approximately 8 employees.
Echo Therapeutics has completed 10 funding rounds, raising a total of $44.70M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Echo Therapeutics include Nemaura Medical, Undermyfork, Pacific Diabetes Technologies Inc, Signos, Medtrum Technologies Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Echo Therapeutics and Nemaura Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Echo Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy